Delcath Systems (DCTH) Operating Income Growth (3y) (2014 - 2026)
Delcath Systems (DCTH) Operating Income Growth (3y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | -3.76% |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | 8.39% |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 6.17% |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | 25.88% |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | 7.13% |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 75.54% |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | -2.70% |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 34.83% |
| 10 | Delcath Systems | 432.25 Mn | 342.96 Mn | 21.26 Mn | 41.85% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 41.85% |
| Dec 31, 2025 | 34.73% |
| Sep 30, 2025 | 63.79% |
| Jun 30, 2025 | 31.48% |
| Mar 31, 2025 | 27.59% |
| Dec 31, 2024 | 38.43% |
| Sep 30, 2024 | 42.71% |
| Jun 30, 2024 | 15.36% |
| Mar 31, 2024 | -15.18% |
| Dec 31, 2023 | -17.43% |
| Sep 30, 2023 | -28.46% |
| Jun 30, 2023 | -23.27% |
| Mar 31, 2023 | -17.94% |
| Dec 31, 2022 | -20.07% |
| Sep 30, 2022 | -13.62% |
| Jun 30, 2022 | -31.97% |
| Mar 31, 2022 | -13.71% |
| Dec 31, 2021 | 15.37% |
| Sep 30, 2021 | -4.94% |
| Jun 30, 2021 | -1.93% |